La chimiothérapie intrapéritonéale avec hyperthermie

  • O. Glehen
  • F.-N. Gilly
Part of the Abord clinique book series (ONCOLPRAT)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bonnefoi H, A’Hern RP, Fisher C et al. (1999) Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 17: 767–75PubMedGoogle Scholar
  2. 2.
    McGuire WP, Hoskins WJ, Brady MF et al. (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334: 1–6CrossRefPubMedGoogle Scholar
  3. 3.
    Piccart MJ, Bertelsen K, James K et al. (2000) Randomized intergroup trial of cisplatinpaclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 92: 699–708CrossRefPubMedGoogle Scholar
  4. 4.
    Bristow RE, Tomacruz RS, Armstrong DK et al. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248–59CrossRefPubMedGoogle Scholar
  5. 5.
    Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6: 727–31CrossRefPubMedGoogle Scholar
  6. 6.
    Sugarbaker PH, Welch L, Mohamed F et al. (2003) A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 12: 605–21PubMedGoogle Scholar
  7. 7.
    Verwaal VJ, van Ruth S, de Bree E et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21: 3737–43CrossRefPubMedGoogle Scholar
  8. 8.
    Glehen O, Kwiatkowski F, Sugarbaker PH et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22: 3284–92CrossRefPubMedGoogle Scholar
  9. 9.
    Glehen O, Schreiber V, Cotte E et al. (2004) Treatment of peritoneal carcinomatosis arising from gastric cancer by cytoreductive surgery and intraperitoneal chemohyperthermia. Arch Surg 139: 20–6PubMedGoogle Scholar
  10. 10.
    Jacquet P, Sugarbaker PH (1996) Peritoneal-plasma barrier. Cancer Treat Res 82: 53–63PubMedGoogle Scholar
  11. 11.
    Leypoldt JK, Parker HR, Frigon RP et al. (1987) Molecular size dependence of peritoneal transport. J Lab Clin Med 110: 207–16PubMedGoogle Scholar
  12. 12.
    Dedrick RL, Myers CE, Bungay PM et al. (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62: 1–11PubMedGoogle Scholar
  13. 13.
    Barlogie B, Corry PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res 40: 1165–8PubMedGoogle Scholar
  14. 14.
    Gerweck LE (1985) Hyperthermia in cancer therapy: the biological basis and unresolved questions. Cancer Res 45: 3408–14PubMedGoogle Scholar
  15. 15.
    Oleson JR, Calderwood SK, Coughlin CT et al. (1988) Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol 11: 368–80PubMedGoogle Scholar
  16. 16.
    Reinhold HS, Endrich B (1986) Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 2: 111–37PubMedGoogle Scholar
  17. 17.
    Lefor AT, Foster CE, 3rd, Sartor W et al. (1994) Hyperthermia increases intercellular adhesion molecule-1 expression and lymphocyte adhesion to endothelial cells. Surgery 116: 214–20; discussion 220–1PubMedGoogle Scholar
  18. 18.
    Glehen O, Beaujard AC, Arvieux C et al. (2002) Les carcinoses péritonéales. Traitement chirurgical, péritonectomies et chimiohyperthermie intrapéritonéale. Gastroenterol Clin Biol 26: 210–5PubMedGoogle Scholar
  19. 19.
    Pestieau SR, Belliveau JF, Griffin H et al. (2001) Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies. J Surg Oncol 76: 106–14CrossRefPubMedGoogle Scholar
  20. 20.
    Los G, Sminia P, Wondergem J et al. (1991) Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 27: 472–7PubMedGoogle Scholar
  21. 21.
    Los G, van Vugt MJ, Pinedo HM (1994) Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 69: 235–41PubMedGoogle Scholar
  22. 22.
    Masuda H, Tanaka T, Matsushima S (1998) Hyperthermic enhancement of cisplatininduced generation of active oxygen radicals in a cell-free system. Anticancer Res 18: 1473–7PubMedGoogle Scholar
  23. 23.
    Hettinga JV, Konings AW, Kampinga HH (1997) Reduction of cellular cisplatin resistance by hyperthermia—a review. Int J Hyperthermia 13: 439–57PubMedGoogle Scholar
  24. 24.
    Raaphorst GP, Doja S, Davis L et al. (1996) A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 37: 574–80CrossRefPubMedGoogle Scholar
  25. 25.
    Elias DM, Ouellet JF (2001) Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin N Am 10: 915–33, xiPubMedGoogle Scholar
  26. 26.
    Spratt JS, Adcock RA, Muskovin M et al. (1980) Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40: 256–60PubMedGoogle Scholar
  27. 27.
    Koga S, Hamazoe R, Maeta M et al. (1984) Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 44: 1840–2PubMedGoogle Scholar
  28. 28.
    Fujimoto S, Shrestha RD, Kokubun M et al. (1988) Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208: 36–41PubMedGoogle Scholar
  29. 29.
    Gilly FN, Carry PY, Sayag AC et al. (1990) Traitement des carcinoses péritonéales par chimiohyperthermie intrapéritonéale. Première expérience. Ann Chir 44: 545–51PubMedGoogle Scholar
  30. 30.
    Gilly FN, Carry PY, Sayag AC et al. (1994) Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41: 124–9PubMedGoogle Scholar
  31. 31.
    Zoetmulder FAN, Verwaal V, Ruth S (2002) Hyperthermic intra peritoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. ASCO Abstract no 586Google Scholar
  32. 32.
    Yonemura Y, Fujimura T, Nishimura G et al. (1996) Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119: 437–44PubMedGoogle Scholar
  33. 33.
    Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14: 254–61CrossRefPubMedGoogle Scholar
  34. 34.
    Ceelen WP, Hesse U, de Hemptinne B et al. (2000) Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 87: 1006–15CrossRefPubMedGoogle Scholar
  35. 35.
    Witkamp AJ, de Bree E, Van Goethem R et al. (2001) Rationale and techniques of intraoperative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27: 365–74CrossRefPubMedGoogle Scholar
  36. 36.
    Begossi G, Gonzalez-Moreno S, Ortega-Perez G et al. (2002) Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. Eur J Surg Oncol 28: 80–7CrossRefPubMedGoogle Scholar
  37. 37.
    Elias D, Antoun S, Raynard B et al. (1999) Traitement des carcinoses péritonéales par exérèse complète et chimiohyperthermie intrapéritonéale. Étude de phase I-II permettant de définir la meilleure procédure. Chirurgie 124: 380–9CrossRefPubMedGoogle Scholar
  38. 38.
    Szafnicki K, Cournil M, O’Meara D et al. (1998) Modélisation de la chimiothérapie intrapéritonéale: étude expérimentale et identification de certains aspects thermiques. Bull Cancer 85: 160–6PubMedGoogle Scholar
  39. 39.
    Jacquet P, Stuart OA, Chang D et al. (1996) Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 7: 596–603PubMedGoogle Scholar
  40. 40.
    Elias D, El Otmany A, Bonnay M et al. (2002) Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncology 63: 346–52CrossRefPubMedGoogle Scholar
  41. 41.
    Pestieau SR, Schnake KJ, Stuart OA et al. (2001) Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. Cancer Chemother Pharmacol 47: 269–76PubMedGoogle Scholar
  42. 42.
    Mohamed F, Marchettini P, Stuart OA et al. (2003) A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. Eur J Surg Oncol 29: 261–5CrossRefPubMedGoogle Scholar
  43. 43.
    Panteix G, Guillaumont M, Cherpin L et al. (1993) Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology 50: 366–70PubMedGoogle Scholar
  44. 44.
    Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221: 29–42PubMedGoogle Scholar
  45. 45.
    Glehen O, Mithieux F, Osinsky D et al. (2003) Surgery Combined With Peritonectomy Procedures and Intraperitoneal Chemohyperthermia in Abdominal Cancers With Peritoneal Carcinomatosis: A Phase II Study. J Clin Oncol 21: 799–806CrossRefPubMedGoogle Scholar
  46. 46.
    Kim JY, Bae HS (2001) A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer 4: 27–33CrossRefPubMedGoogle Scholar
  47. 47.
    Elias D, Blot F, El Otmany A et al. (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92: 71–6CrossRefPubMedGoogle Scholar
  48. 48.
    Kim K, Glehen O, Gilly FN (2003) Carcinoses péritonéales primitives et d’origine digestive traitées par chimiohyperthermie intrapéritonéale. Ann Chir SubmissionGoogle Scholar
  49. 49.
    Jacquet P, Stephens AD, Averbach AM et al. (1996) Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 77: 2622–9CrossRefPubMedGoogle Scholar
  50. 50.
    Stephens AD, Alderman R, Chang D et al. (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6: 790–6CrossRefPubMedGoogle Scholar
  51. 51.
    Glehen O, Osinski D, Cotte E et al. (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10: 863–9CrossRefPubMedGoogle Scholar
  52. 52.
    Witkamp AJ, de Bree E, Kaag MM et al. (2001) Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88: 458–63PubMedGoogle Scholar
  53. 53.
    Zanon C, Clara R, Chiappino I et al. (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 28: 1040–5CrossRefPubMedGoogle Scholar
  54. 54.
    Mansvelt B, Bertrand C, Nockerman P et al. (1997) Étude de toxicité et résultats de la chimio-hyperthermie intra-péritonéale chez 28 patients en carcinose péritonéale. Ann Chir 51: 60–7PubMedGoogle Scholar
  55. 55.
    McQuellon RP, Loggie BW, Fleming RA et al. (2001) Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27: 65–73CrossRefPubMedGoogle Scholar
  56. 56.
    Sayag-Beaujard AC, Francois Y, Glehen O et al. (1999) Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 19: 1375–82PubMedGoogle Scholar
  57. 57.
    McQuellon RP, Loggie BW, Lehman AB et al. (2003) Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10: 155–62CrossRefPubMedGoogle Scholar
  58. 58.
    Ryu KS, Kim JH, Ko HS et al. (2004) Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 94: 325–32CrossRefPubMedGoogle Scholar
  59. 59.
    Hager ED, Dziambor H, Hohmann D et al. (2001) Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer. Int J Gynecol Cancer 11Suppl 1: 57–63PubMedGoogle Scholar
  60. 60.
    Deraco M, Rossi CR, Pennacchioli E et al. (2001) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 87: 120–6PubMedGoogle Scholar
  61. 61.
    de Bree E, Romanos J, Michalakis J et al. (2003) Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 23: 3019–27PubMedGoogle Scholar
  62. 62.
    Look M, Chang D, Sugarbaker PH (2003) Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 13: 764–70CrossRefPubMedGoogle Scholar
  63. 63.
    Piso P, Dahlke MH, Loss M et al. (2004) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2: 21PubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2006

Authors and Affiliations

  • O. Glehen
  • F.-N. Gilly

There are no affiliations available

Personalised recommendations